Swine and Avian Influenza Drug Development Pipeline Review, 2017

  • ID: 4434632
  • Report
  • 119 pages
  • GBI Research
1 of 4

H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. There are a total of 63 products in development for this indication, by 47 companies and six academic institutions. Key companies operating in this pipeline space include Gemmus Pharma, Aphios, Fides Pharma, Inovio Pharmaceuticals, Microbiotix, NanoViricides, Shionogi, the University of Wisconsin Madison and Tria Bioscience.

H1N1 Infection also called as swine flu is a new kind of flu in humans. It's caused by the contagious H1N1 influenza virus. There are a total of 99 products in development for this indication, by 67 companies and 14 academic institutions. Key companies operating in this pipeline space include Johnson & Johnson, and the University of Sherbrooke.

In both types of influenza, the most common molecular target being studied is hemagglutinin, by a considerable margin. However, a number of both human and viral proteins are also under active development.

This report provides an overview of the Swine and Avian Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A virus, subtypes H5N1 and H1N1, and features dormant and discontinued projects. Symptoms of influenza include fever and cough, fatigue, acute respiratory distress, shortness of breath, abdominal pain and diarrhea.

Scope

  •  Which companies are the most active within each pipeline?
  •  Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  •  To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  •  What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
READ MORE
Note: Product cover images may vary from those shown
2 of 4

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Swine and Avian Influenza Report Coverage
2.2 Influenza A Virus, H5N1 Subtype Infections – Overview
2.3 Influenza A Virus, H1N1 Subtype Infections – Overview

3 Therapeutics Development
3.1 Influenza A Virus, H5N1 Subtype Infections
3.2 Influenza A Virus, H1N1 Subtype Infections

4 Therapeutics Assessment
4.1 Influenza A Virus, H5N1 Subtype Infections
4.2 Influenza A Virus, H1N1 Subtype Infections
5 Companies Involved in Therapeutics Development
5.1 Influenza A Virus, H5N1 Subtype Infections
5.2 Influenza A Virus, H1N1 Subtype Infections

6 Dormant Projects
6.1 Influenza A Virus, H5N1 Subtype Infections
6.2 Influenza A Virus, H1N1 Subtype Infections
7 Discontinued Products
7.1 Influenza A Virus, H5N1 Subtype Infections
7.2 Influenza A Virus, H1N1 Subtype Infections

8 Product Development Milestones
8.1 Influenza A Virus, H5N1 Subtype Infections
8.2 Influenza A Virus, H1N1 Subtype Infections

9 Appendix
9.1 Methodology
9.2 Coverage
9.3 Secondary Research
9.4 Primary Research
9.5 Expert Panel Validation
9.6 Contact Us
9.7 Disclaimer

List of Tables
Table 1: Number of Products under Development for Influenza A Virus, H5N1 Subtype Infections
Table 2: Number of Products under Development by Companies Influenza A Virus, H5N1 Subtype Infections
Table 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H5N1 Subtype Infections
Table 4: Products under Development by Companies Influenza A Virus, H5N1 Subtype Infections
Table 5: Products under Development by Universities/Institutes Influenza A Virus, H5N1 Subtype Infections
Table 6: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections
Table 7: Number of Products under Development by Companies Influenza A Virus, H1N1 Subtype Infections
Table 8: Number of Products under Development by Universities/Institutes Influenza A Virus, H1N1 Subtype Infections
Table 9: Products under Development by Companies Influenza A Virus, H1N1 Subtype Infections
Table 10: Products under Development by Universities/Institutes Influenza A Virus, H1N1 Subtype Infections
Table 11: Number of Products by Stage and Target Influenza A Virus, H5N1 Subtype Infections
Table 12: Number of Products by Stage and Mechanism of Action Influenza A Virus, H5N1 Subtype Infections
Table 13: Number of Products by Stage and Route of Administration Influenza A Virus, H5N1 Subtype Infections
Table 14: Number of Products by Stage and Molecule Type Influenza A Virus, H5N1 Subtype Infections
Table 15: Number of Products by Stage and Target Influenza A Virus, H1N1 Subtype Infections
Table 16: Number of Products by Stage and Mechanism of Action Influenza A Virus, H1N1 Subtype Infections
Table 17: Number of Products by Stage and Route of Administration Influenza A Virus, H1N1 Subtype Infections
Table 18: Number of Products by Stage and Molecule Type Influenza A Virus, H1N1 Subtype Infections
Table 19: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Akshaya Bio Inc
Table 20: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Altimmune Inc
Table 21: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Antigen Express Inc
Table 22: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Aphios Corp
Table 23: Influenza A Virus, H5N1 Subtype Infections – Pipeline by BiondVax Pharmaceuticals Ltd
Table 24: Influenza A Virus, H5N1 Subtype Infections – Pipeline by CEL-SCI Corp
Table 25: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Cocrystal Pharma Inc
Table 26: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Curevac AG
Table 27: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Gemmus Pharma Inc
Table 28: Influenza A Virus, H5N1 Subtype Infections – Pipeline by GlaxoSmithKline Plc
Table 29: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Hemispherx Biopharma Inc
Table 30: Influenza A Virus, H5N1 Subtype Infections – Pipeline by iBio Inc
Table 31: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc
Table 32: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Johnson & Johnson
Table 33: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Kineta Inc
Table 34: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Lakewood-Amedex Inc
Table 35: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Medicago Inc
Table 36: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Medigen Vaccine Biologics Corp
Table 37: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Microbiotix Inc
Table 38: Influenza A Virus, H5N1 Subtype Infections – Pipeline by NanoBio Corp
Table 39: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Nanotherapeutics Inc
Table 40: Influenza A Virus, H5N1 Subtype Infections – Pipeline by NanoViricides Inc
Table 41: Influenza A Virus, H5N1 Subtype Infections – Pipeline by OPKO Health Inc
Table 42: Influenza A Virus, H5N1 Subtype Infections – Pipeline by PaxVax Inc
Table 43: Influenza A Virus, H5N1 Subtype Infections – Pipeline by PeptiDream Inc
Table 44: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Shionogi & Co Ltd
Table 45: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Takeda Pharmaceutical Company Ltd
Table 46: Influenza A Virus, H5N1 Subtype Infections – Pipeline by TechnoVax Inc
Table 47: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Vaxart Inc
Table 48: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Vaxine Pty Ltd
Table 49: Influenza A Virus, H5N1 Subtype Infections – Pipeline by Visterra Inc
Table 50: Influenza A Virus, H1N1 Subtype Infections – Pipeline by AbbVie Inc
Table 51: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Adimmune Corp
Table 52: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Akshaya Bio Inc
Table 53: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Altimmune Inc
Table 54: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Antigen Express Inc
Table 55: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Beijing Minhai Biotechnology Co Ltd
Table 56: Influenza A Virus, H1N1 Subtype Infections – Pipeline by BioCryst Pharmaceuticals Inc
Table 57: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Cadila Healthcare Ltd
Table 58: Influenza A Virus, H1N1 Subtype Infections – Pipeline by CEL-SCI Corp
Table 59: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Cilian AG
Table 60: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Cocrystal Pharma Inc
Table 61: Influenza A Virus, H1N1 Subtype Infections – Pipeline by ContraFect Corp
Table 62: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Curevac AG
Table 63: Influenza A Virus, H1N1 Subtype Infections – Pipeline by EpiVax Inc
Table 64: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Etubics Corp
Table 65: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Gemmus Pharma Inc
Table 66: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Genentech Inc
Table 67: Influenza A Virus, H1N1 Subtype Infections – Pipeline by iBio Inc
Table 68: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc
Table 69: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd
Table 70: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Johnson & Johnson
Table 71: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Kineta Inc
Table 72: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Kyowa Hakko Kirin Co Ltd
Table 73: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Lakewood-Amedex Inc
Table 74: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Medicago Inc
Table 75: Influenza A Virus, H1N1 Subtype Infections – Pipeline by MedImmune LLC
Table 76: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Microbiotix Inc
Table 77: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Mucosis BV
Table 78: Influenza A Virus, H1N1 Subtype Infections – Pipeline by NanoViricides Inc
Table 79: Influenza A Virus, H1N1 Subtype Infections – Pipeline by NewLink Genetics Corp
Table 80: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Novavax Inc
Table 81: Influenza A Virus, H1N1 Subtype Infections – Pipeline by OPKO Health Inc
Table 82: Influenza A Virus, H1N1 Subtype Infections – Pipeline by PeptiDream Inc
Table 83: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Recce Ltd
Table 84: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Sanofi
Table 85: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Sanofi Pasteur SA
Table 86: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Sarepta Therapeutics Inc
Table 87: Influenza A Virus, H1N1 Subtype Infections – Pipeline by SK Chemicals Co Ltd
Table 88: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Takeda Pharmaceutical Company Ltd
Table 89: Influenza A Virus, H1N1 Subtype Infections – Pipeline by TechnoVax Inc
Table 90: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Touchlight Genetics Ltd
Table 91: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Vaccibody AS
Table 92: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Vaxart Inc
Table 93: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Vironova AB
Table 94: Influenza A Virus, H1N1 Subtype Infections – Pipeline by Visterra Inc
Table 95: Influenza A Virus, H5N1 Subtype Infections – Dormant Projects
Table 96: Influenza A Virus, H1N1 Subtype Infections – Dormant Projects
Table 97: Influenza A Virus, H5N1 Subtype Infections – Discontinued Products
Table 98: Influenza A Virus, H1N1 Subtype Infections – Discontinued Products

List of Figures
Figure 1: Number of Products under Development for Influenza A Virus, H5N1 Subtype Infections
Figure 2: Number of Products under Development by Companies Influenza A Virus, H5N1 Subtype Infections
Figure 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H5N1 Subtype Infections
Figure 4: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections
Figure 5: Number of Products under Development by Companies Influenza A Virus, H1N1 Subtype Infections
Figure 6: Number of Products under Development by Universities/Institutes Influenza A Virus, H1N1 Subtype Infections
Figure 7: Number of Products by Top 10 Targets Influenza A Virus, H5N1 Subtype Infections
Figure 8: Number of Products by Stage and Top 10 Targets Influenza A Virus, H5N1 Subtype Infections
Figure 9: Number of Products by Top 10 Mechanism of Actions Influenza A Virus, H5N1 Subtype Infections
Figure 10: Number of Products by Stage and Top 10 Mechanism of Actions Influenza A Virus, H5N1 Subtype Infections
Figure 11: Number of Products by Top 10 Routes of Administration Influenza A Virus, H5N1 Subtype Infections
Figure 12: Number of Products by Stage and Top 10 Routes of Administration Influenza A Virus, H5N1 Subtype Infections
Figure 13: Number of Products by Top 10 Molecule Types Influenza A Virus, H5N1 Subtype Infections
Figure 14: Number of Products by Stage and Top 10 Molecule Types Influenza A Virus, H5N1 Subtype Infections
Figure 15: Number of Products by Top 10 Targets Influenza A Virus, H1N1 Subtype Infections
Figure 16: Number of Products by Stage and Top 10 Targets Influenza A Virus, H1N1 Subtype Infections
Figure 17: Number of Products by Top 10 Mechanism of Actions Influenza A Virus, H1N1 Subtype Infections
Figure 18: Number of Products by Stage and Top 10 Mechanism of Actions Influenza A Virus, H1N1 Subtype Infections
Figure 19: Number of Products by Top 10 Routes of Administration Influenza A Virus, H1N1 Subtype Infections
Figure 20: Number of Products by Stage and Top 10 Routes of Administration Influenza A Virus, H1N1 Subtype Infections
Figure 21: Number of Products by Top 10 Molecule Types Influenza A Virus, H1N1 Subtype Infections
Figure 22: Number of Products by Stage and Top 10 Molecule Types Influenza A Virus, H1N1 Subtype Infections

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll